Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans

Hypertension

Volumn 57, Issue 1, 2011, Pages 70-78

  Idei, Naomi ^a   Nishioka, Kenji ^a   Soga, Junko ^a   Hidaka, Takayuki ^a   Hata, Takaki ^a   Fujii, Yuichi ^a   Fujimura, Noritaka ^a   Maruhashi, Tatsuya ^a   Mikami, Shinsuke ^a   Teragawa, Hiroki ^a   Kihara, Yasuki ^a   Noma, Kensuke ^a   Chayama, Kazuaki ^a   Higashi, Yukihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

atherosclerosis obliterans; Buerger's disease; circulating progenitor cells; endothelial function; oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; METFORMIN; SULFONYLUREA; VASCULOTROPIN;

ARTICLE; BLOOD FLOW; BLOOD LEVEL; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; BUERGER DISEASE; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL MIGRATION; CIRCULATION; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; STEM CELL; VASODILATATION;

ADULT; ARTERIOSCLEROSIS OBLITERANS; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CELL COUNT; CROSS-SECTIONAL STUDIES; DEOXYGUANOSINE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITROGLYCERIN; STEM CELLS; THROMBOANGIITIS OBLITERANS; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASODILATION;

EID: 78650957646     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.163683     Document Type: Article

References (41)

1. Lüscher TF. Imbalance of endothelium-derived relaxing and contracting factors. Am J Hypertens. 1990;3:317-330.
2. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
3. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
4. Vanhoutte PM. Endothelium and control of vascular function: state of the art lecture. Hypertension. 1989;13:658-667.
5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340:115-126.
6. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vascu-lature of patients with thromboangiitis obliterans (Buerger's disease). Circulation. 1996;94:II211-II215.
7. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108:2093-2098.
8. Higashi Y, Kimura M, Hara K, Goto C, Noma K, Jitsuiki D, Nakagawa K, Oshima T, Chayama K, Sueda T, Matsubara H, Murohara T, Yoshizumi M. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation. 2004;109:1215-1218.
9. Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T. Vascular function in patients with peripheral arterial disease: a comparison of upper and lower extremities. Atherosclerosis. 2005;178: 179-185.
10. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
11. Ohta T, Shionoya S. Fate of the ischaemic limb in Buerger's disease. Br J Surg. 1988;75:259-262.
12. Mills JL, Porter JM. Buerger's disease: a review and update. Semin Vasc Surg. 1993;6:14-23.
13. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
15. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007. (Pubitemid 41262334)
16. Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol. 1998;66:S243-S245.
17. Soga J, Nishioka K, Nakamura S, Umemura T, Jitsuiki D, Hidaka T, Teragawa H, Goto C, Chayama K, Yoshizumi M, Higashi Y. Measurement of flow-mediated vasodilation of the brachial artery: a comparison of measurements in the sitting and supine positions. Circ J. 2007;71:736-740.
18. Higashi Y, Matsuoka H, Umei H, Sugano R, Soga J, Fujii Y, Chayama K, Kihara Y, Imaizumi T. Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells. Am J Physiol Endorinol Metab. 2010;298:E202-E209.
19. Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothe-lial cell migration. FEBS Lett. 2000;477:258-262.
20. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45:1219-1222.
21. Higashi Y, Jitsuiki D, Goto C, Umemura T, Nishioka K, Hidaka T, Takemoto T, Nakamura S, Nakagawa K, Oshima T, Chayama K, Yoshizumi M, Taguchi A. Periodontal infection is associated with endo-thelial dysfunction in humans. Hypertension. 2008;51:446-453.
22. Olfert IM, Breen EC, Mathieu-Costello O, Wagner PD. Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J Appl Physiol. 2001;91:1176-1184. (Pubitemid 32807721)
23. Gustafsson T, Kraus WE. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci. 2001;6:D75-D89.
24. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. Am J Physiol Heart Circ Physiol. 2010;298:H2174-H2191.
25. Matsui K, Yoshioka T, Murakami Y, Takahashi M, Shimada K, Ikeda U. Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease. Circ J. 2003;67:660-662. (Pubitemid 36950779)
26. Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;52:387-393.
27. Papamichael CM, Lekakis JP, Stamatelopoulos KS, Papaioannou TG, Alevizaki MK, Cimponeriu AT, Kanakakis JE, Papapanagiotou A, Kalo-foutis AT, Stamatelopoulos SF. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;15:86:615-618.
28. Bode-Boger SM, Boger RH, Alfke H, Heinzel D, Tsikas D, Creung A, Alexander K, Frolisch JC. L-arginine induces nitric-oxide dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation. 1996;93:85-90.
29. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol. 2001;87:324-329.
30. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation. 2002; 106:1133-1139.
31. Ballard VL, Edelberg JM. Stem cells and regeneration of aging cardiovascular system. Circ Res. 2007;100:1116-1127.
32. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
33. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
34. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
35. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, Kropf J, Kerber S, Breithardt G, Assmann G, Cullen P. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol. 1999;19:2355-2363.
36. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, Pratt RE, Dzau VJ. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res. 2006;99: 315-322.
37. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol. 2006;48:1579-1587.
38. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004; 109:2058-2067.
39. Szuba A, Cooke JP. Thromboangiitis obliterans. An update on Buerger's disease. West J Med. 1998;168:255-260.
40. Cooper LT, Tse TS, Mikhail MA, McBane RD, Stanson AW, Ballman KV. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol. 2004;44:2410-2411.
41. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E III, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K, TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1-S75. (Pubitemid 46068992)